31 March 2020
Biomolecules Reaches 2000 Article Milestone
![](https://pub.mdpi-res.com/announcement/1879.jpg?1721979229)
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
Biomolecules (ISSN 2218-273X) is an international, peer reviewed, and open access journal focusing on biogenic substances, and published monthly online by MDPI. Biomolecules has passed another milestone by publishing the 2000th article since its inception in 2011.
Biomolecules is now indexed in Science Citation Index Expanded (Web of Science), Scopus, and PubMed. Biomolecules received an Impact Factor of 4.694 in 2019, which corresponds to a ranking of 58 out of 298 (80.70%, Q1) in the JCR category 'Biochemistry and Molecular Biology'. Biomolecules’ current CiteScore in Scopus is 5.72, ranking 33 out of 407 (Q1) in the category 'Biochemistry' and 44 out 375 (Q1) in the category 'Molecular Biology'.
Our sincere thanks to the Editor-in-Chief of Biomolecules, Dr. Vladimir N. Uversky, and all Editorial Board members as well as Guest Editors of Special Issues, who ensure the continued significance of the journal.